Membranous Nephropathy Associated With the Relatively Selective Cyclooxygenase-2 Inhibitor, Etodolac, in a Patient With Early Rheumatoid Arthritis
Internal Medicine - Japan
doi 10.2169/internalmedicine.46.0094
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2007
Authors
Publisher
Japanese Society of Internal Medicine